Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Clinical trial NCT01241292 · COMPLETED

Trial details

NCT number: NCT01241292
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2011-01-14
Primary completion: 2014-02-14
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.